Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
Acrivon Therapeutics, Inc. (ACRV)
Company Research
Source: Yahoo! Finance
Acrivon Therapeutics, Inc. (ACRV) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Acrivon Therapeutics, Inc. is a member of our Medical group, which includes 1047 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Acrivon Therapeutics, Inc. is currently sporting a Zacks Rank of #2 (Buy). O
Show less
Read more
Impact Snapshot
Event Time:
ACRV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACRV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRV alerts
High impacting Acrivon Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ACRV
News
- SAGE's Huntington's Disease Study Meets Primary Endpoint [Yahoo! Finance]Yahoo! Finance
- Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Acrivon Therapeutics to Present at the Jefferies Global Healthcare ConferenceGlobeNewswire
- Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock [Yahoo! Finance]Yahoo! Finance
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $25.00 price target on the stock.MarketBeat
ACRV
Earnings
- 5/14/24 - Beat
ACRV
Sec Filings
- 5/21/24 - Form 4
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- ACRV's page on the SEC website